Financial statements Consulting Pharm
Balance sheet data of CONSULTING PHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 678 049,22 | 422 728,30 | 461 759,86 | 458 389,93 | 463 772,67 | 466 550,64 |
| A. Fixed assets | 2 902,41 | 266 768,85 | 285 597,56 | 236 877,14 | 222 306,30 | 315 353,62 |
| B. Current assets | 675 146,81 | 155 959,45 | 176 162,30 | 221 512,79 | 241 466,37 | 151 197,02 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | - | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 50 000,00 | 40 000,00 | - | - |
| Total liabilities | 678 049,22 | 422 728,30 | 461 759,86 | 458 389,93 | 463 772,67 | 466 550,64 |
| A. Equity | -84 837,19 | -136 044,79 | -273 723,88 | -238 598,52 | -302 748,10 | -351 611,61 |
| B. Liabilities and provisions for liabilities | 762 886,41 | 558 773,09 | 735 483,74 | 696 988,45 | 766 520,77 | 818 162,25 |
| I. Long-term liabilities | - | 71 000,00 | - | - | - | - |
| II. Short-term liabilities | - | 487 773,09 | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.